论文信息 - Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone - 字舞流文

Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone

D. Amadori | V. Conteduca | D. Calistri | U. de Giorgi | S. Salvi | G. Attard | U. Giorgi | L. Rossi | E. Bianchi | V. Casadio | E. Carretta | S. Burgio | C. Menna | C. Masini